Emmanuel Chartier‐Kastler

10.2k total citations
373 papers, 6.9k citations indexed

About

Emmanuel Chartier‐Kastler is a scholar working on Urology, Rheumatology and Surgery. According to data from OpenAlex, Emmanuel Chartier‐Kastler has authored 373 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Urology, 189 papers in Rheumatology and 133 papers in Surgery. Recurrent topics in Emmanuel Chartier‐Kastler's work include Urinary Bladder and Prostate Research (182 papers), Pelvic floor disorders treatments (175 papers) and Urological Disorders and Treatments (77 papers). Emmanuel Chartier‐Kastler is often cited by papers focused on Urinary Bladder and Prostate Research (182 papers), Pelvic floor disorders treatments (175 papers) and Urological Disorders and Treatments (77 papers). Emmanuel Chartier‐Kastler collaborates with scholars based in France, United Kingdom and United States. Emmanuel Chartier‐Kastler's co-authors include P. Denys, Morgan Rouprêt, François Richard, V. Phé, Éva Compérat, Marc‐Olivier Bitker, Brigitte Schurch, Christophe Vaessen, André Reitz and François Haab and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Emmanuel Chartier‐Kastler

350 papers receiving 6.6k citations

Peers

Countries citing papers authored by Emmanuel Chartier‐Kastler

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Chartier‐Kastler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Chartier‐Kastler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Chartier‐Kastler more than expected).

Fields of papers citing papers by Emmanuel Chartier‐Kastler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Chartier‐Kastler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Chartier‐Kastler. The network helps show where Emmanuel Chartier‐Kastler may publish in the future.

Co-authorship network of co-authors of Emmanuel Chartier‐Kastler

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Chartier‐Kastler. A scholar is included among the top collaborators of Emmanuel Chartier‐Kastler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Chartier‐Kastler. Emmanuel Chartier‐Kastler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterizing Urine and Sediment in Individuals with Lower Urinary Tract Dysfunction Utilizing Intermittent Catheters 2025 ·Journal of Clinical Medicine ·Per Bagi, Christina Kruuse, (unknown), (unknown), (unknown), Márcio Augusto Averbeck, Michael Kennelly, Nikesh Thiruchelvam, Emmanuel Chartier‐Kastler, Charalampos Konstantinidis, Andrei V. Krassioukov, (unknown)	0
2	137 - The new artificial urinary sphincter UroActive™ (UroMems): results of the first in man implantation study at 6 months post-activation (SOPHIA study) 2024 ·Continence ·(unknown), Marie‐Aimée Perrouin‐Verbe, (unknown), (unknown), Juliette Cotte, (unknown), (unknown), Pierre Mozer, Emmanuel Chartier‐Kastler	1
3	Continent cutaneous diversion: Unveiling the interplay of neuro-urology and oncological challenges 2024 ·PubMed ·(unknown), Emmanuel Chartier‐Kastler, Jérôme Parra, Christophe Vaessen, Morgan Rouprêt, Thomas Seisen, Louis Lenfant	1
4	Association between frailty and detrusor overactivity with detrusor underactivity in older women 2024 ·Neurourology and Urodynamics ·(unknown), Thomas F. Monaghan, Emmanuel Chartier‐Kastler, Mirko Petrović, An‐Sofie Goessaert, Karel Everaert, G. Robain, Rebecca Haddad	3
5	How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity 2024 ·Neurourology and Urodynamics ·(unknown), B. Peyronnet, Marianne de Sèze, A. Even, (unknown), G. Amarenco, Emmanuel Chartier‐Kastler, L. Le Normand, A. Manunta, G. Karsenty, J. Kerdraon, A. Ruffion, C. Saussine, F. Le Breton, (unknown), É. Castel-Lacanal, P. Denys, V. Phé, X. Gamé	2
6	Robot-assisted Periprostatic Artificial Urinary Sphincter Implantation in Men with Neurogenic Stress Urinary Incontinence: Description of the Surgical Technique and Comparison of Long-term Functional Outcomes with the Open Approach 2023 ·European Urology ·Edward H. Lambert, Emmanuel Chartier‐Kastler, Christophe Vaessen, (unknown), Juliette Cotte, Morgan Rouprêt, Pierre Mozer, Jérôme Parra, Thomas Seisen, Louis Lenfant	3
7	Risk factors for urinary tract infections associated with lower quality of life among intermittent catheter users 2023 ·British Journal of Nursing ·Márcio Augusto Averbeck, Michael Kennelly, Nikesh Thiruchelvam, Charalampos Konstantinidis, Emmanuel Chartier‐Kastler, Andrei V. Krassioukov, Malene Hornbak, (unknown), (unknown), Sabrina Islamoska	4
8	Effectiveness of Early Radical Cystectomy for High-Risk Non-Muscle Invasive Bladder Cancer 2022 ·Cancers ·(unknown), M. Roumiguié, Alexandre Ingels, Jérôme Parra, Dimitri Vordos, (unknown), Emmanuel Chartier‐Kastler, M. Soulié, Alexandre de la Taille, Morgan Rouprêt, Thomas Seisen	4
9	Long‐term device survival after a first implantation of AMS800™ for stress urinary incontinence: Comparison between men and women 2022 ·Neurourology and Urodynamics ·Juliette Cotte, Agnès Dechartres, Pierre Mozer, (unknown), Emmanuel Chartier‐Kastler, (unknown)	2
10	Alpha‐blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta‐analysis. A report from the Neuro‐Urology Promotion Committee of the International Continence Society (ICS) 2019 ·Neurourology and Urodynamics ·Marc P. Schneider, Jure Tornic, (unknown), (unknown), Livio Mordasini, Jan Krhút, Emmanuel Chartier‐Kastler, Melissa Davies, Jerzy B. Gajewski, Brigitte Schurch, Lucas M. Bachmann, Thomas M. Kessler	12
11	Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections 2019 ·Advances in Urology ·Michael Kennelly, Nikesh Thiruchelvam, Márcio Augusto Averbeck, (unknown), Emmanuel Chartier‐Kastler, (unknown), (unknown), Andrei V. Krassioukov, (unknown)	59
12	Catheterization for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review. A report from the Neuro‐Urology Promotion Committee of the International Continence Society (ICS) 2018 ·Neurourology and Urodynamics ·Jure Tornic, Andrea M. Sartori, Jerzy B. Gajewski, Ashley Cox, Marc P. Schneider, (unknown), Livio Mordasini, Emmanuel Chartier‐Kastler, Lucas M. Bachmann, Thomas M. Kessler	7
13	International Continence Society best practice statement for use of sacral neuromodulation 2018 ·Neurourology and Urodynamics ·Howard B. Goldman, Jessica C. Lloyd, Karen Noblett, Marcus Carey, Juan Carlos Castaño Botero, Jerzy B. Gajewski, Paul‐Antoine Lehur, Magdy Hassouna, Klaus E. Matzel, Ian M. Paquette, Stefan De Wachter, Michael Ehlert, Emmanuel Chartier‐Kastler, Steven Siegel	122
14	Sustained improvements in health-related quality of life following repeat onabotulinumtoxinA detrusor injections in patients with neurogenic detrusor overactivity: results from two phase 3 studies 2013 ·Neurourology and Urodynamics ·Emmanuel Chartier‐Kastler, Eric Rovner, Michael B. Chancellor, (unknown), (unknown)	1
15	Long-term Functional Outcomes After Ileal Ureter Substitution: A Single-center Experience 2011 ·Urology ·(unknown), Emmanuel Chartier‐Kastler, Pierre Mozer, A Haertig, Marc‐Olivier Bitker, Morgan Rouprêt	48
16	Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats 2009 ·Neurourology and Urodynamics ·Dong Broquères-You, Delphine Behr‐Roussel, S. Oger, Sandrine Compagnie, Stéphanie Caisey, P. Denys, Emmanuel Chartier‐Kastler, François Giuliano	2
17	Évaluation « coût conséquence » d’une nouvelle approche thérapeutique par la toxine botulinique pour la prise en charge des patients neurologiques présentant une hyperactivité du détrusor 2009 ·Journal de Pharmacie Clinique ·(unknown), A. Ruffion, P. Denys, X. Gamé, G. Amarenco, M. De Sèze, F. Haab, G. Karsenty, J. Kerdraon, B. Perrouin-Verbe, J.-M. Soler, C. Saussine, Emmanuel Chartier‐Kastler, G. Aulagner	1
18	Chapitre H - Les conséquences neuro-urologiques de la chirurgie de l’incontinence urinaire d’effort et de la statique pelvienne 2007 ·Progrès en Urologie ·Emmanuel Chartier‐Kastler, N. Ayoub, Pierre Mozer, François Richard, A. Ruffion	0
19	Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review 2007 ·European Urology ·G. Karsenty, P. Denys, G. Amarenco, Marianne de Sèze, X. Gamé, François Haab, J. Kerdraon, B. Perrouin-Verbe, A. Ruffion, C. Saussine, J.-M. Soler, Brigitte Schurch, Emmanuel Chartier‐Kastler	247
20	Malformation du système veineux rénal et cave caudal révélée par des hématuries récidivantes 1995 ·Progrès en Urologie ·Thierry Lebrét, Emmanuel Chartier‐Kastler, Pierre Conort, (unknown), C Chatelain	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact